A randomized trial to investigate the efficacy and safety of insulin glargine in hyperglycemic acute stroke patients receiving intensive care
Abstract This pilot, randomized, open-label controlled study compared the basal–bolus regimens of insulin glargine (IG) and neutral protamine Hagedorn (NPH) insulin in stroke patients with hyperglycemia receiving intensive care. The study recruited acute stroke patients requiring intensive care with...
Guardado en:
Autores principales: | Sung-Chun Tang, Shyang-Rong Shih, Shin-Yi Lin, Chih-Hao Chen, Shin-Joe Yeh, Li-Kai Tsai, Wei-Shiung Yang, Jiann-Shing Jeng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/c49257a3ce804cdc8125f9e6e2841a90 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
On the safety of insulin Glargine
por: Ivan Ivanovich Dedov, et al.
Publicado: (2009) -
Proteinuria independently predicts unfavorable outcome of ischemic stroke patients receiving intravenous thrombolysis.
por: Chih-Hao Chen, et al.
Publicado: (2013) -
Lantus (Insulin Glargin): new insulin on Russian market
por: Editorial team Diabetes Mellitus
Publicado: (2003) -
Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes
por: Tarigan TJE, et al.
Publicado: (2021) -
Insulin glargine: pharmacokinetic and pharmacodynamic basis of clinical effect
por: Vadim Valer'evich Klimontov, et al.
Publicado: (2014)